Home | Stock Market Blogs | Financial Tools | Sign Up Free

Biotechnology & Drugs Market Industry
More Pages: Page: (1)
OTC PK:BLFEBio-Life Labs, Inc.
 Bio-Life Labs, Inc. is a research-driven biotechnology company focused on discovery, development, and commercialization of breakthrough treatments for Cancer, Diabetes Mellitus, and Hepatitus C.
 Market CapDay's VolumeLast TradeChange
AMEX:ONIOragenics, Inc.
 Oragenics is an early-stage biotechnology company focused on enhancing novel technologies and products sourced from research at the University of Florida and other academic centers, as well as discovered internally. Co. has licensed two technologies from the University of Florida: replacement therapy for the prevention of tooth decay and mutacin 1140, a novel antibiotic. Co. has also developed a probiotics technology to provide protection against the causative organisms of periodontal disease and has licensed two related platform technologies that enable the identification of gene targets associated with the natural onset and progression of infections, cancers and other diseases.
 Market CapDay's VolumeLast TradeChange
 Threshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of drugs based on Metabolic Targeting, an approach that targets core differences in metabolism between normal and certain diseased cells. Co.'s clinical focus is on product candidates for the treatment of cancer. At Dec 31 2006, Co. had three product candidates for these programs, for which it held sole worldwide marketing rights: Glufosfamide for the potential treatment of cancer; 2-deoxyglucose for the potential treatment of cancer; and TH-302 , which is a hypoxically activated prodrug for the potential treatment of solid tumors.
 Market CapDay's VolumeLast TradeChange
NYSE:TBVTiens Biotech Group
 Tiens Biotech Group USA researches, develops, manufactures, and markets nutrition supplement products, including wellness products and dietary supplement products and personal care products. Co.'s operations are conducted from its headquarters in Tianjin, People's Republic of China (China) through its 80.0% owned subsidiary, Tianjin Tianshi Biological Development Co. Ltd. As of Dec 31 2006, Co. sold its products to affiliated companies in China and 63 countries internationally. Co. registered its products under the logo Tiens with the State Administration of Industry and Commerce in China.
 Market CapDay's VolumeLast TradeChange
OTC PK:XNOMXenomics, Inc.
 Xenomics, Inc. is a biotech company that is currently in development of a new and proprietary gateway technology based upon Transrenal DNA. This technology is expected to create a marketing gateway for many genetic testing services that today are not available to the public.
 Market CapDay's VolumeLast TradeChange
More Pages: Page: (1)

Investing by Industry or Market Sector employs non-emotional, numbers driven, value-based industry, sector, and country rotation techniques, that, unlike conventional stock picking methods, focuses instead on identifying and capitalizing on theme movements in the well identified industries & market sectors.

Primarily, this active-asset methodology recognizes that advances in financial markets are defined by "themes", or led by asset classes, industries, and countries, with each advance distinguished by specific sector-driven themes. Employing a disciplined research and valuation process these "themes" are identified so that Portfolio's can be created and/or adjusted toward the most attractive sectors.

Home | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign UpCopyright 2014
SmallCapWatch, LLC.
Never invest based soley on information from this website or our e-mail and IM alerts